Takeda Pharmaceutical Company Limited (NYSE: TAK)
Drug Manufacturers - General · Tokyo, Japan · Founded 1781
- Market capitalization: $45.0 billion
- Annual revenue: $30.0 billion
- Net income: $-0.08 billion
- Employees: 49,000
- Sector: Healthcare
- Headquarters: Tokyo, Japan
- Founded: 1781
Source: Statvoo company profile for Takeda Pharmaceutical Company Limited. Browse all 500+ companies
Takeda is Japan's largest pharmaceutical company and one of the top 10 globally, focused on rare diseases, gastroenterology, neuroscience, and oncology. The $62 billion acquisition of Shire in 2019 transformed them from a Japan-centric pharma into a global biopharma player. They're headquartered in Tokyo but run largely from Boston.
Prescription drug sales globally, with a portfolio weighted toward rare diseases and specialty medicines that command premium pricing. The Shire acquisition brought blockbusters like Entyvio (GI) and a leading rare disease franchise. They've been divesting non-core assets to pay down acquisition debt.
Founded in 1781 in Osaka — yes, over 240 years ago — Takeda is one of the oldest pharmaceutical companies in the world. The Shire acquisition in 2019 was the largest foreign takeover by a Japanese company ever. CEO Christophe Weber has been driving the global transformation since 2015.
| Market Capitalization | $45.0B |
| Annual Revenue | $30.0B |
| Net Income | $-0.08B |
| Profit Margin | 0% |
| Revenue per Employee | $612245K |
| Stock Exchange | NYSE |
| Ticker Symbol | TAK |
Financial data is approximate and based on most recent annual filings.
Takeda has been in business for over 240 years, predating the United States. The Shire deal made Takeda the world's largest rare disease company overnight.
Takeda's Shire bet was bold and is paying off. The rare disease and GI franchises are strong, but the debt paydown needs to continue.
What is Takeda Pharmaceutical Company Limited's revenue?
Takeda Pharmaceutical Company Limited generates approximately $30.0 billion in annual revenue.
How many employees does Takeda Pharmaceutical Company Limited have?
Takeda Pharmaceutical Company Limited employs approximately 49,000 people worldwide.
What is Takeda Pharmaceutical Company Limited's market cap?
Takeda Pharmaceutical Company Limited (TAK) has a market capitalization of approximately $45.0 billion on the NYSE.
When was Takeda Pharmaceutical Company Limited founded?
Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.
Who is the CEO of Takeda Pharmaceutical Company Limited?
Christophe Weber is the current CEO of Takeda Pharmaceutical Company Limited.
What is Takeda Pharmaceutical Company Limited's website?
Takeda Pharmaceutical Company Limited's official website is takeda.com.
| CEO | Christophe Weber |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Founded | 1781 |
| HQ | Tokyo |
| Country | Japan |
| Website | takeda.com |
See traffic, security, and technical data for Takeda Pharmaceutical Company Limited's website:
📊 takeda.com stats 📋 WHOIS 🌐 DNS 🔒 SSL